Ameriprise Financial Inc. Has $3.19 Million Stock Position in Vital Farms, Inc. (NASDAQ:VITL)

Ameriprise Financial Inc. grew its position in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 25.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,592 shares of the company's stock after purchasing an additional 17,017 shares during the period. Ameriprise Financial Inc. owned 0.19% of Vital Farms worth $3,188,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Proficio Capital Partners LLC acquired a new stake in Vital Farms during the 4th quarter valued at $699,000. Barclays PLC grew its position in Vital Farms by 57.3% in the 3rd quarter. Barclays PLC now owns 95,444 shares of the company's stock worth $3,347,000 after purchasing an additional 34,758 shares during the last quarter. Vanguard Group Inc. raised its stake in Vital Farms by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 2,236,848 shares of the company's stock valued at $84,307,000 after acquiring an additional 87,980 shares in the last quarter. Vontobel Holding Ltd. bought a new stake in shares of Vital Farms during the fourth quarter valued at about $298,000. Finally, Geode Capital Management LLC lifted its stake in shares of Vital Farms by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 761,380 shares of the company's stock worth $28,703,000 after acquiring an additional 11,721 shares during the period. Hedge funds and other institutional investors own 98.59% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on VITL. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective on the stock in a research note on Friday, February 28th. DA Davidson cut their target price on Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a research report on Friday, March 14th. Morgan Stanley reduced their price objective on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Telsey Advisory Group reissued an "outperform" rating and issued a $52.00 target price on shares of Vital Farms in a research report on Monday, May 5th. Finally, William Blair restated an "outperform" rating on shares of Vital Farms in a research report on Friday, February 28th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $44.63.

Vital Farms Stock Up 0.5%

Shares of NASDAQ:VITL traded up $0.17 during midday trading on Thursday, hitting $31.95. 433,349 shares of the stock were exchanged, compared to its average volume of 1,026,274. The company has a market capitalization of $1.42 billion, a PE ratio of 28.53 and a beta of 0.94. Vital Farms, Inc. has a 52-week low of $27.91 and a 52-week high of $48.41. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The business's fifty day simple moving average is $33.36 and its two-hundred day simple moving average is $35.00.

Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.11. The company had revenue of $162.19 million for the quarter, compared to analyst estimates of $164.43 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The business's revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.43 EPS. As a group, research analysts predict that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Insider Transactions at Vital Farms

In related news, CEO Russell Diez-Canseco sold 45,124 shares of the firm's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total value of $1,520,227.56. Following the transaction, the chief executive officer now owns 703,736 shares in the company, valued at $23,708,865.84. This trade represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Matthew Ohayer sold 4,000 shares of the business's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $31.39, for a total value of $125,560.00. Following the sale, the insider now directly owns 6,966,890 shares of the company's stock, valued at $218,690,677.10. This represents a 0.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 93,124 shares of company stock worth $3,019,308. 27.60% of the stock is owned by insiders.

About Vital Farms

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.